| Mr David Bart Reuben, MD | |
|
1245 16th St Ste 204, Santa Monica, CA 90404-1240 | |
| (310) 319-4371 | |
| (310) 319-4141 |
| Full Name | Mr David Bart Reuben |
|---|---|
| Gender | Male |
| Speciality | Geriatric Medicine |
| Experience | 47 Years |
| Location | 1245 16th St Ste 204, Santa Monica, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427078690 | NPI | - | NPPES |
| 00G664270 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | G66427 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ronald Reagan Ucla Medical Center | Los angeles, CA | Hospital |
| Santa Monica - Ucla Med Ctr & Orthopaedic Hospital | Santa monica, CA | Hospital |
| Cedars-sinai Medical Center | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Regents Of The University Of California | 1355248584 | 1177 |
News Archive
A major new pediatric research study led by a Wayne State University researcher, funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) and published this week in the New England Journal of Medicine (NEJM), has "major implications" for the treatment of urinary tract infections (UTIs) in millions of American children.
Butler Hospital in Providence, R.I., is leading a clinical study evaluating the effectiveness and safety of deep brain stimulation (DBS) for severe obsessive-compulsive disorder (OCD).
People who severely restrict their caloric intake drastically reduce their risk of developing diabetes or clogged arteries, the precursor to a heart attack or stroke. In fact, according to researchers at Washington University School of Medicine in St Louis, some risk factors were so low they were comparable to those of people decades younger.
A University of Denver study shows a curriculum-based bullying prevention program reduced incidents of bullying by 20 percent, twice as much as in the study control group.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
› Verified 1 days ago
| Entity Name | The Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235107566 PECOS PAC ID: 1355248584 Enrollment ID: O20031223000439 |
News Archive
A major new pediatric research study led by a Wayne State University researcher, funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) and published this week in the New England Journal of Medicine (NEJM), has "major implications" for the treatment of urinary tract infections (UTIs) in millions of American children.
Butler Hospital in Providence, R.I., is leading a clinical study evaluating the effectiveness and safety of deep brain stimulation (DBS) for severe obsessive-compulsive disorder (OCD).
People who severely restrict their caloric intake drastically reduce their risk of developing diabetes or clogged arteries, the precursor to a heart attack or stroke. In fact, according to researchers at Washington University School of Medicine in St Louis, some risk factors were so low they were comparable to those of people decades younger.
A University of Denver study shows a curriculum-based bullying prevention program reduced incidents of bullying by 20 percent, twice as much as in the study control group.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr David Bart Reuben, MD 5767 W. Century Blvd., Suite 400, Los Angeles, CA 90045-5655 Ph: (310) 301-8714 | Mr David Bart Reuben, MD 1245 16th St Ste 204, Santa Monica, CA 90404-1240 Ph: (310) 319-4371 |
News Archive
A major new pediatric research study led by a Wayne State University researcher, funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) and published this week in the New England Journal of Medicine (NEJM), has "major implications" for the treatment of urinary tract infections (UTIs) in millions of American children.
Butler Hospital in Providence, R.I., is leading a clinical study evaluating the effectiveness and safety of deep brain stimulation (DBS) for severe obsessive-compulsive disorder (OCD).
People who severely restrict their caloric intake drastically reduce their risk of developing diabetes or clogged arteries, the precursor to a heart attack or stroke. In fact, according to researchers at Washington University School of Medicine in St Louis, some risk factors were so low they were comparable to those of people decades younger.
A University of Denver study shows a curriculum-based bullying prevention program reduced incidents of bullying by 20 percent, twice as much as in the study control group.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
› Verified 1 days ago
Irawan Susanto, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1223 16th St, Suite 3400, Santa Monica, CA 90404 Phone: 310-449-0939 Fax: 424-259-7790 | |
Louis Ravitz, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 2336 Santa Monica Blvd, Suite 207, Santa Monica, CA 90404 Phone: 310-828-9311 Fax: 310-453-8533 | |
Janet Winikoff, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 2001 Santa Monica Blvd Ste 860, Santa Monica, CA 90404 Phone: 310-828-3209 Fax: 310-828-5165 | |
Dr. Sean Dooley, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 Santa Monica Blvd, Santa Monica, CA 90404 Phone: 323-829-8745 | |
Lorraine Anderson, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1245 16th St Ste 303, Santa Monica, CA 90404 Phone: 310-481-4646 Fax: 310-899-7599 | |
Dr. Colleen Lucy Channick, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1223 16th St Ste 3400, Santa Monica, CA 90404 Phone: 310-449-0939 | |
Carol Yukiko Nishikubo, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Santa Monica Blvd Ste 560w, Santa Monica, CA 90404 Phone: 310-453-5654 Fax: 310-453-6885 |